{"doi":"10.1002/ana.26776","title":"Detection of <scp>High‐Risk</scp> Paraneoplastic Antibodies against <scp>TRIM9</scp> and <scp>TRIM67</scp> Proteins","abstract":"OBJECTIVE: Co-occurring anti-tripartite motif-containing protein 9 and 67 autoantibodies (TRIM9/67-IgG) have been reported in only a very few cases of paraneoplastic cerebellar syndrome. The value of these biomarkers and the most sensitive methods of TRIM9/67-IgG detection are not known. METHODS: We performed a retrospective, multicenter study to evaluate the cerebrospinal fluid and serum of candidate TRIM9/67-IgG cases by tissue-based immunofluorescence, peptide phage display immunoprecipitation sequencing, overexpression cell-based assay (CBA), and immunoblot. Cases in which TRIM9/67-IgG was detected by at least 2 assays were considered TRIM9/67-IgG positive. RESULTS: Among these cases (n = 13), CBA was the most sensitive (100%) and revealed that all cases had TRIM9 and TRIM67 autoantibodies. Of TRIM9/67-IgG cases with available clinical history, a subacute cerebellar syndrome was the most common presentation (n = 7/10), followed by encephalitis (n = 3/10). Of these 10 patients, 70% had comorbid cancer (7/10), 85% of whom (n = 6/7) had confirmed metastatic disease. All evaluable cancer biopsies expressed TRIM9 protein (n = 5/5), whose expression was elevated in the cancerous regions of the tissue in 4 of 5 cases. INTERPRETATION: TRIM9/67-IgG is a rare but likely high-risk paraneoplastic biomarker for which CBA appears to be the most sensitive diagnostic assay. ANN NEUROL 2023;94:1086-1101.","journal":"Annals of Neurology","year":2023,"id":340116,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":16,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9666,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2023-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":393420,"name":"Thomas Ngo","orcid":"0000-0003-2504-1872","position":1,"is_corresponding":false},{"id":1074434,"name":"Le Duy","orcid":"0000-0001-7664-533X","position":2,"is_corresponding":false},{"id":312359,"name":"Αναστασία Ζεκερίδου","orcid":"0000-0002-1960-9065","position":3,"is_corresponding":false},{"id":246845,"name":"Ravi Dandekar","orcid":"0000-0002-2930-3043","position":4,"is_corresponding":false},{"id":661382,"name":"Sergio Muñiz‐Castrillo","orcid":"0000-0001-5958-3288","position":5,"is_corresponding":false},{"id":284369,"name":"Bonny D. Alvarenga","orcid":"0000-0001-7922-9454","position":6,"is_corresponding":false},{"id":104237,"name":"Kelsey C. Zorn","orcid":"0000-0003-1227-2137","position":7,"is_corresponding":false},{"id":1074435,"name":"Asritha Tubati","orcid":"0009-0003-5303-1214","position":8,"is_corresponding":false},{"id":661385,"name":"Anne‐Laurie Pinto","orcid":"0009-0004-5127-3137","position":9,"is_corresponding":false},{"id":964738,"name":"Weston D. Browne","orcid":null,"position":10,"is_corresponding":false},{"id":490767,"name":"Patrick W. Hullett","orcid":"0000-0002-0894-1767","position":11,"is_corresponding":false},{"id":936276,"name":"Mark Terrelonge","orcid":"0000-0001-9079-6150","position":12,"is_corresponding":false},{"id":246843,"name":"Ryan Schubert","orcid":"0000-0002-3132-5831","position":13,"is_corresponding":false},{"id":854713,"name":"Amanda L. Piquet","orcid":"0000-0001-7349-6455","position":14,"is_corresponding":false},{"id":1075125,"name":"Binxia Yang","orcid":null,"position":15,"is_corresponding":false},{"id":854266,"name":"Mayra Montalvo","orcid":"0000-0003-1386-9998","position":16,"is_corresponding":false},{"id":818669,"name":"Andrew F. Kung","orcid":null,"position":17,"is_corresponding":false},{"id":284367,"name":"Sabrina A Mann","orcid":"0000-0002-4970-1073","position":18,"is_corresponding":false},{"id":826262,"name":"Maulik Shah","orcid":"0009-0007-0261-7054","position":19,"is_corresponding":false},{"id":347892,"name":"Michael D. Geschwind","orcid":"0000-0003-2861-3776","position":20,"is_corresponding":false},{"id":246851,"name":"Jeffrey M. Gelfand","orcid":"0000-0002-5121-3319","position":21,"is_corresponding":false},{"id":107235,"name":"Joseph L. DeRisi","orcid":"0000-0002-4611-9205","position":22,"is_corresponding":false},{"id":231254,"name":"Sean J. Pittock","orcid":"0000-0002-6140-5584","position":23,"is_corresponding":false},{"id":457161,"name":"Jérôme Honnorat","orcid":"0000-0002-4721-5952","position":24,"is_corresponding":false},{"id":393421,"name":"Samuel J. Pleasure","orcid":"0000-0001-8599-1613","position":25,"is_corresponding":false},{"id":109296,"name":"Michael R. Wilson","orcid":"0000-0002-8705-5084","position":26,"is_corresponding":false},{"id":411545,"name":"Christopher M. Bartley","orcid":"0000-0002-1391-4130","position":0,"is_corresponding":true}],"reference_count":45,"raw_metadata":null,"created_at":"2026-07-19T01:10:54.145367Z","pmid":"37632288","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}